iXpressGenes' Grant

iXpressGenes raised a round of funding on January 12, 2016. Investors include U.S. Department of Defense.

iXpressGenes is a synthetic biology company that specializes in protein services and instrumentation, and protein and genetic engineering research. The company supports commercial, institutional and a…

Articles about iXpressGenes' Grant: